<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01560455</url>
  </required_header>
  <id_info>
    <org_study_id>EBC TWO</org_study_id>
    <nct_id>NCT01560455</nct_id>
  </id_info>
  <brief_title>European Bifurcation Club Trial - Two-stent Versus One-stent Technique for Large Bifurcation Lesions</brief_title>
  <acronym>EBC TWO</acronym>
  <official_title>The European Bifurcation Coronary Study; A Randomised Comparison Of Provisional T-Stenting Versus A Systematic Two Stent Strategy In Large Calibre True Bifurcations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Sussex County Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Terumo Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Sussex County Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine use of two-stent versus one-stent techniques for patients with large
      calibre bifurcation lesions including significant side branch disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment of bifurcation coronary lesions remains a difficult area, in which best practice is
      yet to be established. Prior to the era of drug-eluting stents, the limited data which
      existed suggested that a strategy of stenting the main vessel, with balloon angioplasty alone
      of the side-branch if required was superior to stenting both vessels.

      Randomised trials of &quot;all-comer&quot; bifurcation lesions have now established that there is no
      advantage to systematic dual drug-eluting stent strategies. However, these trials included
      patients with no disease in the side branch, and small side branch vessels.

      Expert consensus suggests that &quot;large&quot; bifurcations with significant ostial side branch
      disease still merit a systematic total lesion coverage stent technique. This trial therefore
      is designed to assess the hypothesis that large true bifurcations with significant side
      branch ostial disease are more successfully treated with a systematic culotte technique than
      with the provisional T approach.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite primary endpoint (Death, MI, TVR)</measure>
    <time_frame>12 months</time_frame>
    <description>Death Myocardial infarction Target Vessel Revascularisation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>12 months</time_frame>
    <description>Stent thrombosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>single stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>single stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dual stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dual stent (culotte)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>single stent</intervention_name>
    <description>single stent</description>
    <arm_group_label>single stent</arm_group_label>
    <other_name>Terumo Nobori stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>two stent</intervention_name>
    <description>culotte</description>
    <arm_group_label>dual stent</arm_group_label>
    <other_name>Terumo Nobori stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &quot;True&quot; coronary bifurcation lesion (i.e. &gt;50% lesion in both main vessel and side
             branch) requiring revascularisation

          -  Main vessel ≥ 2.5mm diameter (visual inspection)

          -  Side branch ≥ 2.5mm diameter (visual inspection)

          -  Side branch ostial lesion ≥5mm length

          -  Patient ≥18 years old

          -  Females of childbearing potential: -ve pregnancy test

        Exclusion Criteria:

          -  Acute ST elevation myocardial infarction

          -  Cardiogenic shock

          -  Left main stem lesion of haemodynamic significance

          -  Chronic total occlusion of either vessel

          -  Additional Type C lesions requiring PCI

          -  Either bifurcation vessel not suitable for stenting

          -  Platelet count ≤50 x 109/mm3

          -  Left ventricular ejection fraction ≤20%

          -  Patient life expectancy less than 12 months

          -  Known allergies to aspirin, clopidogrel, heparin, stainless steel, intravenous
             contrast (severe), or stent drug elutant

          -  Participation in another investigational drug or device study

          -  Patient unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sussex Cardiac Centre</name>
      <address>
        <city>Brighton</city>
        <state>East Sussex</state>
        <zip>BN2 1DE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2011</study_first_submitted>
  <study_first_submitted_qc>March 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2012</study_first_posted>
  <last_update_submitted>March 11, 2016</last_update_submitted>
  <last_update_submitted_qc>March 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Royal Sussex County Hospital</investigator_affiliation>
    <investigator_full_name>David Hildick-Smith</investigator_full_name>
    <investigator_title>Consultant Cardiologist</investigator_title>
  </responsible_party>
  <keyword>stent</keyword>
  <keyword>bifurcation</keyword>
  <keyword>coronary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

